Gene · 11167
Papers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer. | Discov Oncol | 2025 | 41296128 | PubTator, text mining | PubMed |
| Aqueous Humor Proteome in RVO-Associated Macular Edema: Analysis during Three Consecutive Conbercept Treatments. | ACS Omega | 2025 | 41280838 | PubTator, text mining | PubMed |
| The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer. | Cancer Immunol Immunother | 2025 | 41251805 | PubTator, text mining | PubMed |
| Exercise intensity affects circulating C1q/TNF-related proteins and follistatin-like 1 concentrations. | Clin Physiol Funct Imaging | 2025 | 41236124 | PubTator, text mining | PubMed |
| Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens. | Cells | 2025 | 41227333 | PubTator, text mining | PubMed |
| Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study. | Sci Rep | 2025 | 41198895 | PubTator, text mining | PubMed |
| Circulating organokines in coronary artery disease and metabolic syndrome: FABP4, adiponectin, irisin, FSTL1. | Biomol Biomed | 2025 | 41187309 | PubTator, text mining | PubMed |
| FSTL1 promotes osteoclast differentiation and Accelerates periprosthetic osteolysis via PP2A Cα-Mediated activation of the JNK signaling pathway. | Biochem Pharmacol | 2025 | 41130306 | PubTator, text mining | PubMed |
| Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases. | Int J Mol Sci | 2025 | 41096976 | PubTator, text mining | PubMed |
| [Transcriptomic Profile of the Trastuzumab-Resistant Breast Cancer Cell Line BT-474]. | Mol Biol (Mosk) | 2025 | 41090333 | PubTator, text mining | PubMed |
| Brown remodeling of white adipose tissue protects against abdominal aortic aneurysm via batokine FSTL1. | EMBO Mol Med | 2025 | 41068431 | PubTator, text mining | PubMed |
| Composition of cardiac-derived extracellular vesicles changes with vesicle origin and determines uptake. | Front Cardiovasc Med | 2025 | 41030476 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates. | Int J Mol Sci | 2025 | 41009363 | PubTator, text mining | PubMed |
| The Role of Selected Myokines in the Development of Cardiovascular Diseases, and Their Involvement in Developing Heart Failure in Rheumatoid Arthritis Patients. | Int J Mol Sci | 2025 | 40943120 | PubTator, text mining | PubMed |
| Immune Characteristics of eQTL and Gene Risk Model and the Inhibitory Effect of DCTD and RRAS on Ferroptosis in Glioblastoma. | Front Biosci (Landmark Ed) | 2025 | 40917066 | PubTator, text mining | PubMed |
| A molecular systems architecture of the mesenchymal stromal cell microenvironment. | Stem Cells | 2025 | 40843515 | PubTator, text mining | PubMed |
| Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis. | Hepatology | 2025 | 40833998 | PubTator, text mining | PubMed |
| Elucidating the role of LGALS3BP in coronary atherosclerosis: integrating bioinformatics and machine learning for advanced insights. | J Cardiothorac Surg | 2025 | 40814096 | PubTator, text mining | PubMed |
| Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis. | Front Pharmacol | 2025 | 40808692 | PubTator, text mining | PubMed |
| Dynamic changes of systemic and local myokines in burn patients undergoing physiotherapy: A pilot prospective study. | Burns | 2025 | 40768787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11167/papers?page=4